M. B. Stocks

699 total citations
11 papers, 488 citations indexed

About

M. B. Stocks is a scholar working on Molecular Biology, Cancer Research and Mechanical Engineering. According to data from OpenAlex, M. B. Stocks has authored 11 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Cancer Research and 2 papers in Mechanical Engineering. Recurrent topics in M. B. Stocks's work include RNA modifications and cancer (6 papers), RNA Research and Splicing (4 papers) and Cancer-related molecular mechanisms research (3 papers). M. B. Stocks is often cited by papers focused on RNA modifications and cancer (6 papers), RNA Research and Splicing (4 papers) and Cancer-related molecular mechanisms research (3 papers). M. B. Stocks collaborates with scholars based in United Kingdom. M. B. Stocks's co-authors include Vincent Moulton, Tamás Dalmay, Simon Moxon, Irina Mohorianu, Leighton Folkes, Hugh Woolfenden, Frank Schwach, Daniel Mapleson, György Szittya and Stephen D. Laycock and has published in prestigious journals such as Nucleic Acids Research, Bioinformatics and RNA.

In The Last Decade

M. B. Stocks

11 papers receiving 478 citations

Peers

M. B. Stocks
Comparison fields: 5 of 60
  • Molecular Biology 298
  • Plant Science 288
  • Cancer Research 145
  • Endocrinology 25
  • Ecology 12
Replace Yubang Gao with:
Yubang Gao China
Nikoleta A. Τzioutziou United Kingdom
Jean‐Malo Couzigou France
Qinglian Wang China
Uciel Chorostecki Spain
Xiaomin Zheng China
Guilherme Loss-Morais Brazil
Alexandra Boutla Greece
Claudia Castillo-González United States
Damián A. Cambiagno Argentina
Yubang Gao China View profile →
Citations per field, relative to M. B. Stocks
M. B. Stocks · 1×
Citations per year, relative to M. B. Stocks
M. B. Stocks · 1×

Countries citing papers authored by M. B. Stocks

Since Specialization
Citations

This map shows the geographic impact of M. B. Stocks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. B. Stocks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. B. Stocks more than expected).

Fields of papers citing papers by M. B. Stocks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. B. Stocks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. B. Stocks. The network helps show where M. B. Stocks may publish in the future.

Co-authorship network of co-authors of M. B. Stocks

This figure shows the co-authorship network connecting the top 25 collaborators of M. B. Stocks. A scholar is included among the top collaborators of M. B. Stocks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. B. Stocks. M. B. Stocks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
# Work Indexed citations
1 40
2 22
3 15
4 31
5 21
6 85
7 244
8 9
9 2
10 17
11 2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026